JenaValve announced today that it began patient enrollment in the ARTIST study evaluating its Trilogy heart valve system.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.

The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

Jaipur's Rajasthan Hospital achieved a medical milestone by replacing a heart valve non-surgically through the arm artery.

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

You know our consumer advisor, Clark Howard, as someone who saves you time and money. But did you know he had a near-death ...

Five people in the East of England have become the first to benefit from a pioneering treatment for heart valve disease at ...